Common stock offering initiated in 2012
Company: Riot
The claim, verbatim
The company raised funds through a common stock offering beginning in 2012 to support remaining development and clinical trial work needed to seek FDA clearance for AppyScore™
Source (primary)
Riot DEF 14A filed 2012-10-15 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “Since the beginning of 2012, the Company has raised funds through a common stock offering to be used principally to perform the remaining development and clinical trial work needed to seek FDA clearance for its blood-based diagnostic test”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Riot DEF 14A filed 2012-10-15
Quote: “Since the beginning of 2012, the Company has raised funds through a common stock offering to be used principally to perform the remaining development and clinical trial work needed to seek FDA clearance for its blood-based diagnostic test”